Table 2.
Logistic regression analyses for sustained Hepatitis Be antigen seroconversion at week 12
| Characteristics |
Univariate analysis
|
Multivariate analysis
|
||||
|
OR
|
95%CI
|
P value
|
OR
|
95%CI
|
P value
|
|
| ALT | 1.002 | 0.998-1.002 | 0.383 | 1.008 | 0.999-1.014 | 0.063 |
| IL-21 | 0.999 | 0.994-1.004 | 0.645 | |||
| PDL1 | 0.957 | 0.891-1.029 | 0.236 | |||
| CXCR5 | 1.038 | 0.953-1.131 | 0.395 | 0.652 | 0.387-1.098 | 0.107 |
| PDL1+CD8+ | 1.070 | 0.959-1.193 | 0.225 | |||
| PDL1+CD4+ (%) | 0.85 | 0.733-0.984 | 0.018a | |||
| CXCR5+CD8+ | 1.459 | 1.125-1.892 | 0.004b | 4.820 | 1.081-21.487 | 0.039a |
| CXCR5+CD4+ | 0.952 | 0.853-1.062 | 0.375 | |||
| log10 HBV DNA | 0.412 | 0.241-0.705 | 0.001b | |||
| log10 HBsAg | 0.126 | 0.032-0.507 | 0.004b | |||
| log10 HBeAg | 0.300 | 0.144-0.626 | 0.001b | 0.009 | 0.001-0.490 | 0.021a |
P < 0.05.
P < 0.01.
ALT: Alanine aminotransferase; HBV: Hepatitis B virus; HBeAg: Hepatitis Be antigen; IL-21: Interleukin-21; CXCR5: C-X-C chemokine receptor type 5; PD-L1: Programmed death-ligand 1.